This fundie couldn’t be happier with her portfolio

Joyce Meng is a presenter at this year’s Sohn Hearts & Minds Investment Leaders Conference on November 18, which takes place in Hobart and aims to raise money for medical research.

This fundie couldn’t be happier with her portfolio

November 7, 2022
Joyce Meng is a presenter at this year’s Sohn Hearts & Minds Investment Leaders Conference on November 18, which takes place in Hobart and aims to raise money for medical research.
Read Transcript

The US recession of 2023, if it were to happen, won’t be a repeat of the 1970s, or the 1940s.

“I think we should all be students of history, but not use simplified narratives and analogies to draw conclusions on what to do,” cautions Joyce Meng, the managing partner and founder of New York-based FACT Capital.

Not only are there differences in the energy dynamic playing out between now and historical crises, but information efficiency is also “so much higher” in today’s economy, she says.

Just as Wall Street staged an incredible rally in the depths of COVID-19 while shelter-at-home orders were still in place, two out of the three main US equity benchmarks are in a bear market despite US president Joe Biden’s assurance that the economy is “strong as hell”.

The US added 261,000 jobs in October, according to official labour data released on Friday, but the unemployment rate increased to 3.7 per cent.

“It hasn’t been that bad yet, but stock markets have already fallen in anticipation of [a recession]. And so the speed of discounting, information transmission, is very different,” the fund manager observes.

Today, investors find themselves in a unique place. For hedge funds, the money has already been made on the easy shorts identified by picking off the coronavirus winners: Shopify is down 80 per cent and Netflix more than 60 per cent.

Idiosyncratic opportunities

“We’re in this interesting environment where everyone’s looking at what normalised earnings is, fundamentally. And not only do you have the normal economic cycle, where the Fed is tightening – it has implications across housing assets, consumer borrowing, consumption – but then you also have this COVID ‘digestation’, and the question is, which companies have rebased expectations to a point that’s reasonable versus where is the demand still really, really elevated?”

That is giving rise to some idiosyncratic opportunities for the manager. For example, a listed freight-forwarder comes to mind, which the Street expects to earn more than $US8 a share this year, when its earnings capacity historically is only about $US3.50 a share.

Meng, who declines to name the business, thinks its exposure to falling ocean freight rates sets it up as a weak link, or an over-earner at risk.

“In the short term, stocks don’t work until earnings estimates stabilise,” she says. “And so companies that have already adjusted expectations, have strong predictability of what next year is, and have lowered the bar so that they have a comfortable earnings trajectory, I think those companies are better prepared to perform.”

FACT (fairness, alignment, compounding, transparency) has achieved its three-year anniversary in truly memorable circumstances: the fastest bull market in history, war and now inflation. It has still managed to exceed its benchmark with a return for the long-short strategy of 21.9 per cent against the MSCI All Country World Index at 15.1 per cent.

Meng is a presenter at this year’s Sohn Hearts & Minds Investment Leaders Conference on November 18, which takes place in Hobart, and aims to raise money for medical research.

“FACT’s strategy has always been very GAARP in nature – growth at a reasonable price,” says Meng.

The nature of the bear market has penalised growth stocks, whose valuations suffer disproportionately to value stocks in a rising interest rate environment. However, Meng has put her portfolio through its paces and concluded that there is nothing she would rather own.

Beauty Health Company, the parent of the patented HydraFacial skin treatment and the stock idea she pitched to Sohn’s audience in 2021, is still an outright winner in FACT’s micro-themed universe of which skincare is one such thematic.

“It’s a very profitable name, has earnings support, but it was one of those mid-cap growth names” and that tilt “definitely hurt us this year”.

In the wreckage of high-multiple and unprofitable technology stocks, disciplined investors have lots to be encouraged by, even if the cycle is not yet realigned to re-rate those companies demonstrating exciting growth.

We can find 20 per cent compounders at like 10 times PE, and that would be the type that we’re really shooting for.

— Joyce Meng

“The good news is, I think with the rate hikes, the unlimited amount of capital that can support unsustainable business models with questionable unit economics – that’s gone. And so I think in some ways, it creates a lot more discipline, it rewards incumbents that have like strong ROI [return on investment], strong market share.”

Value stocks, she argues, still cannot escape their intrinsic reliance on the economic cycle, such as iron ore producers.

“There’s some question on what recession would look like for value names that are a little bit more cyclical, and so we like growth at a reasonable valuation because there’s more in the company’s control. But at the same time, they’re justifiable even using conservative cost of equity.”

There is such a thing, Meng adds, as companies that have both value and growth characteristics.

“We can find 20 per cent compounders at like 10 times PE [price-to-earnings multiple], and that would be the type that we’re really shooting for.”

Growth and China

The other source of pressure on returns is the fund’s preference for China exposure, historically around 30 per cent: “We can flex up and down depending on the opportunity set we see. Growth and China have had a challenging year, but we really like our book,” says Meng.

Another micro-theme on the FACT radar is Brazil’s agricultural export growth, represented by a long position in Rumo Logistica. “Rumo is a beneficiary of China’s search for food security as Brazil grain exports to China grow,” the manager says.

The falling Brazilian real has led Rumo – which provides storage and transportation to bulk agricultural product providers – to declare that it is cheaper to ship soybeans to China from Brazil, than the US.

Meng presented Rumo as a long idea at the philanthropic Robin Hood Foundation conference in New York last month.

Other micro-thematics are the global labour arbitrage in digital services, commercial aerospace recovery, and cloud “hyperscalers” at reasonable valuations. Tactically, with a view to present market conditions, Meng is a fan of companies that have “taken their medicine” and set realistic expectations for next year, small- and mid-cap stocks relative to large caps, and trading the “first-in, first-out” dynamic where “normalisation fears have already resulted in multiple and earnings overshooting”.

‘Resilience’

Meng is a bull on the longer-term thematic of consumption in China.

“For China to be more self-reliant in the face of geopolitical concerns, the government has to enable a resilient domestic economy and not just depend on foreign exports,” which she cites as being about 20 per cent of GDP. “China consumption as a percentage of GDP is incredibly low – household private consumption is only 40 per cent versus the US around 70 per cent.

“When [president] Xi talks about resilience, strong domestic demand and circulation is required.”

That is problematic in the short-term, where lockdowns are still a tool of China’s coronavirus mitigation strategy.

“That being said, as the pressures on the economy build, we expect gradual reopening – we’ve already seen international flights doubling in Q4, restoration of the Beijing marathon maskless, and moderation in the public media tone on the dangers of COVID.

“Notably, we think there will be winners and losers within consumption and stock picking opportunities.”

The Australian Financial Review is a media partner of sohnheartsandminds.com.au.

 

Disclaimer: This material has been prepared by AFR, published on 7 November 2022. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

The US recession of 2023, if it were to happen, won’t be a repeat of the 1970s, or the 1940s.

“I think we should all be students of history, but not use simplified narratives and analogies to draw conclusions on what to do,” cautions Joyce Meng, the managing partner and founder of New York-based FACT Capital.

Not only are there differences in the energy dynamic playing out between now and historical crises, but information efficiency is also “so much higher” in today’s economy, she says.

Just as Wall Street staged an incredible rally in the depths of COVID-19 while shelter-at-home orders were still in place, two out of the three main US equity benchmarks are in a bear market despite US president Joe Biden’s assurance that the economy is “strong as hell”.

The US added 261,000 jobs in October, according to official labour data released on Friday, but the unemployment rate increased to 3.7 per cent.

“It hasn’t been that bad yet, but stock markets have already fallen in anticipation of [a recession]. And so the speed of discounting, information transmission, is very different,” the fund manager observes.

Today, investors find themselves in a unique place. For hedge funds, the money has already been made on the easy shorts identified by picking off the coronavirus winners: Shopify is down 80 per cent and Netflix more than 60 per cent.

Idiosyncratic opportunities

“We’re in this interesting environment where everyone’s looking at what normalised earnings is, fundamentally. And not only do you have the normal economic cycle, where the Fed is tightening – it has implications across housing assets, consumer borrowing, consumption – but then you also have this COVID ‘digestation’, and the question is, which companies have rebased expectations to a point that’s reasonable versus where is the demand still really, really elevated?”

That is giving rise to some idiosyncratic opportunities for the manager. For example, a listed freight-forwarder comes to mind, which the Street expects to earn more than $US8 a share this year, when its earnings capacity historically is only about $US3.50 a share.

Meng, who declines to name the business, thinks its exposure to falling ocean freight rates sets it up as a weak link, or an over-earner at risk.

“In the short term, stocks don’t work until earnings estimates stabilise,” she says. “And so companies that have already adjusted expectations, have strong predictability of what next year is, and have lowered the bar so that they have a comfortable earnings trajectory, I think those companies are better prepared to perform.”

FACT (fairness, alignment, compounding, transparency) has achieved its three-year anniversary in truly memorable circumstances: the fastest bull market in history, war and now inflation. It has still managed to exceed its benchmark with a return for the long-short strategy of 21.9 per cent against the MSCI All Country World Index at 15.1 per cent.

Meng is a presenter at this year’s Sohn Hearts & Minds Investment Leaders Conference on November 18, which takes place in Hobart, and aims to raise money for medical research.

“FACT’s strategy has always been very GAARP in nature – growth at a reasonable price,” says Meng.

The nature of the bear market has penalised growth stocks, whose valuations suffer disproportionately to value stocks in a rising interest rate environment. However, Meng has put her portfolio through its paces and concluded that there is nothing she would rather own.

Beauty Health Company, the parent of the patented HydraFacial skin treatment and the stock idea she pitched to Sohn’s audience in 2021, is still an outright winner in FACT’s micro-themed universe of which skincare is one such thematic.

“It’s a very profitable name, has earnings support, but it was one of those mid-cap growth names” and that tilt “definitely hurt us this year”.

In the wreckage of high-multiple and unprofitable technology stocks, disciplined investors have lots to be encouraged by, even if the cycle is not yet realigned to re-rate those companies demonstrating exciting growth.

We can find 20 per cent compounders at like 10 times PE, and that would be the type that we’re really shooting for.

— Joyce Meng

“The good news is, I think with the rate hikes, the unlimited amount of capital that can support unsustainable business models with questionable unit economics – that’s gone. And so I think in some ways, it creates a lot more discipline, it rewards incumbents that have like strong ROI [return on investment], strong market share.”

Value stocks, she argues, still cannot escape their intrinsic reliance on the economic cycle, such as iron ore producers.

“There’s some question on what recession would look like for value names that are a little bit more cyclical, and so we like growth at a reasonable valuation because there’s more in the company’s control. But at the same time, they’re justifiable even using conservative cost of equity.”

There is such a thing, Meng adds, as companies that have both value and growth characteristics.

“We can find 20 per cent compounders at like 10 times PE [price-to-earnings multiple], and that would be the type that we’re really shooting for.”

Growth and China

The other source of pressure on returns is the fund’s preference for China exposure, historically around 30 per cent: “We can flex up and down depending on the opportunity set we see. Growth and China have had a challenging year, but we really like our book,” says Meng.

Another micro-theme on the FACT radar is Brazil’s agricultural export growth, represented by a long position in Rumo Logistica. “Rumo is a beneficiary of China’s search for food security as Brazil grain exports to China grow,” the manager says.

The falling Brazilian real has led Rumo – which provides storage and transportation to bulk agricultural product providers – to declare that it is cheaper to ship soybeans to China from Brazil, than the US.

Meng presented Rumo as a long idea at the philanthropic Robin Hood Foundation conference in New York last month.

Other micro-thematics are the global labour arbitrage in digital services, commercial aerospace recovery, and cloud “hyperscalers” at reasonable valuations. Tactically, with a view to present market conditions, Meng is a fan of companies that have “taken their medicine” and set realistic expectations for next year, small- and mid-cap stocks relative to large caps, and trading the “first-in, first-out” dynamic where “normalisation fears have already resulted in multiple and earnings overshooting”.

‘Resilience’

Meng is a bull on the longer-term thematic of consumption in China.

“For China to be more self-reliant in the face of geopolitical concerns, the government has to enable a resilient domestic economy and not just depend on foreign exports,” which she cites as being about 20 per cent of GDP. “China consumption as a percentage of GDP is incredibly low – household private consumption is only 40 per cent versus the US around 70 per cent.

“When [president] Xi talks about resilience, strong domestic demand and circulation is required.”

That is problematic in the short-term, where lockdowns are still a tool of China’s coronavirus mitigation strategy.

“That being said, as the pressures on the economy build, we expect gradual reopening – we’ve already seen international flights doubling in Q4, restoration of the Beijing marathon maskless, and moderation in the public media tone on the dangers of COVID.

“Notably, we think there will be winners and losers within consumption and stock picking opportunities.”

The Australian Financial Review is a media partner of sohnheartsandminds.com.au.

 

Disclaimer: This material has been prepared by AFR, published on 7 November 2022. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

Disclaimer: This material has been prepared by Australian Financial Review, published on Nov 07, 2022. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
March 14, 2025

$1.4 million boost for SA medical research

South Australian medical research will receive a $1.4 million cash injection, as a direct result of a major investment and philanthropy conference held in Adelaide.

Read More
Anthony Scaramucci’s time in the White House was brief but memorable. APAnthony Scaramucci’s time in the White House was brief but memorable. APAnthony Scaramucci’s time in the White House was brief but memorable. APAnthony Scaramucci’s time in the White House was brief but memorable. AP
May 19, 2025

Why ‘The Mooch’ thinks Trump is more dangerous this time around

Anthony Scaramucci says Trump has fewer constraints on his worst instincts in his second administration. But he still gets bored easily.

Read More
Image caption: Anthony “The Mooch” Scaramucci at the New York headquarters of his SkyBridge Capital last week. Picture: Jaclyn LichtImage caption: Anthony “The Mooch” Scaramucci at the New York headquarters of his SkyBridge Capital last week. Picture: Jaclyn LichtImage caption: Anthony “The Mooch” Scaramucci at the New York headquarters of his SkyBridge Capital last week. Picture: Jaclyn LichtImage caption: Anthony “The Mooch” Scaramucci at the New York headquarters of his SkyBridge Capital last week. Picture: Jaclyn Licht
May 19, 2025

My biggest mistake: Anthony Scaramucci on what makes Donald Trump tick

On Elon Musk, money and the White House, fast-talking Wall Street hedge fund manager and former Trump communications director Anthony Scaramucci tells it as he sees it.

Read More
A bull case for Bitcoin even as it trades near record levels. Picture: AFPA bull case for Bitcoin even as it trades near record levels. Picture: AFPA bull case for Bitcoin even as it trades near record levels. Picture: AFPA bull case for Bitcoin even as it trades near record levels. Picture: AFP
May 19, 2025

Bitcoin ‘on track’ for $US200,000: Anthony Scaramucci

Bitcoin could hit as much as $US200,000 ($311,000) by the end of this year, fuelled by surging inflows into exchange-traded funds and Donald Trump’s erratic policymaking.

Read More
Anthony Scaramucci says America has no choice but to lower tariffs on China further. Jaclyn LichtAnthony Scaramucci says America has no choice but to lower tariffs on China further. Jaclyn LichtAnthony Scaramucci says America has no choice but to lower tariffs on China further. Jaclyn LichtAnthony Scaramucci says America has no choice but to lower tariffs on China further. Jaclyn Licht
May 19, 2025

‘The Mooch’ says Trump will have to cut China tariffs below 10pc

Scaramucci, who is best known as The Mooch, is the first big-name global investor to be confirmed for the Sohn Hearts & Minds conference in Sydney in November.

Read More
December 19, 2024

Rikki Bannan – Don’t get caught up in momentum

Conference Fund Manager Rikki Bannan, Executive Director at IFM Investors, joins Equity Mates to discuss her standout 2023 stock pick, Telix, and explore what opportunities lie ahead.

Read More
Nick Moakes of the Wellcome Trust told the Sohn Hearts & Minds conference that some investors were too optimistic about a reduction in rates. Picture: Ben SearcyNick Moakes of the Wellcome Trust told the Sohn Hearts & Minds conference that some investors were too optimistic about a reduction in rates. Picture: Ben SearcyNick Moakes of the Wellcome Trust told the Sohn Hearts & Minds conference that some investors were too optimistic about a reduction in rates. Picture: Ben SearcyNick Moakes of the Wellcome Trust told the Sohn Hearts & Minds conference that some investors were too optimistic about a reduction in rates. Picture: Ben Searcy
November 20, 2024

Trump unifies top investors in decade-long bullish outlook for US

Nick Moakes, CIO of the $72 billion Wellcome Trust, told the conference that too many investors were banking on a return to the ultra-low interest rates that prevailed over the past decade.

Read More
Wall Street legend Howard Marks told the Sohn event that US exceptionalism would endure. Picture: Ben SearcyWall Street legend Howard Marks told the Sohn event that US exceptionalism would endure. Picture: Ben SearcyWall Street legend Howard Marks told the Sohn event that US exceptionalism would endure. Picture: Ben SearcyWall Street legend Howard Marks told the Sohn event that US exceptionalism would endure. Picture: Ben Searcy
November 17, 2024

Is anyone brave or stupid enough to bet against America?

Stock pickers have been punished for betting against the US. The choice between consensus and contrarianism on American exceptionalism is now harder than ever.

Read More
Ellerston Capital's Chris Kourtis says things will improve at embattled fund manager Perpetual. Picture: Ben Searcy PhotographyEllerston Capital's Chris Kourtis says things will improve at embattled fund manager Perpetual. Picture: Ben Searcy PhotographyEllerston Capital's Chris Kourtis says things will improve at embattled fund manager Perpetual. Picture: Ben Searcy PhotographyEllerston Capital's Chris Kourtis says things will improve at embattled fund manager Perpetual. Picture: Ben Searcy Photography
November 15, 2024

Eleven stock tips from Sohn to get you through 2025

“There’s no finer place for the finance festival than in the festival city,” said Matthew Grounds. He, along with fellow Barrenjoey co-executive chairman Guy Fowler and investor Gary Weiss, is one of Sohn’s driving forces.

Read More
November 15, 2024

Howard Marks and Sohn’s big stars reveal seven rules for investing

Among the stock picks and stunts at the Sohh Hearts & Minds event, Howard Marks and Nick Moakes provided investors with long-term rules for playing markets.

Read More
November 15, 2024

Sohn ASX stock pick: Ellerston Capital’s Chris Kourtis backs Perpetual

Chris Kourtis has put his biggest bet on embattled Perpetual – picking one of the most hated stocks on the ASX – that he believes will soon be the ‘cheapest listed asset manager of scale in the universe’.

Read More
Markets will have to adjust to a world in which a new Donald Trump presidency will continue to ‘bash’ Xi Jinping’s China. Picture: AFPMarkets will have to adjust to a world in which a new Donald Trump presidency will continue to ‘bash’ Xi Jinping’s China. Picture: AFPMarkets will have to adjust to a world in which a new Donald Trump presidency will continue to ‘bash’ Xi Jinping’s China. Picture: AFPMarkets will have to adjust to a world in which a new Donald Trump presidency will continue to ‘bash’ Xi Jinping’s China. Picture: AFP
November 15, 2024

Sohn investors position for bullish but bumpy Trump ride

Australia and the rest of the world must adjust to a new Trump presidency that will deliver an expected bull market but also disruption, with the leader in waiting prepared to “create pain” to get his way.

Read More
November 15, 2024

Sohn stock picker experts name best shares to invest in for year ahead

‍Don’t overlook down and out silver miners, legacy skincare brands ready for a revival and a big financial company suffering from a severe case of shareholder wealth destruction.

Read More
November 15, 2024

Sohn: NYSE-listed Estee Lauder’s Northcape Capital pick

Northcape Capital’s Fleur Wright this gives a rare opportunity to buy a high quality company at an attractive price.

Read More
Mike Novogratz, CEO of Galaxy Digital. Photo: Jutharat Pinyodoonyachet/BloombergMike Novogratz, CEO of Galaxy Digital. Photo: Jutharat Pinyodoonyachet/BloombergMike Novogratz, CEO of Galaxy Digital. Photo: Jutharat Pinyodoonyachet/BloombergMike Novogratz, CEO of Galaxy Digital. Photo: Jutharat Pinyodoonyachet/Bloomberg
November 9, 2024

Galaxy Digital CEO Mike Novogratz believes bitcoin will hit $US100k

Bitcoin’s bounce to record highs in recent days is only the beginning of a fresh surge higher for cryptocurrency, says US billionaire Mike Novogratz.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lancaster sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.